KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Co-Diagnostics (CODX) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for Co-Diagnostics (CODX) over the last 7 years, with Q3 2025 value amounting to -$0.16.

  • Co-Diagnostics' EPS (Weighted Average and Diluted) rose 5000.0% to -$0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.99, marking a year-over-year increase of 2826.09%. This contributed to the annual value of -$1.24 for FY2024, which is 305.48% down from last year.
  • As of Q3 2025, Co-Diagnostics' EPS (Weighted Average and Diluted) stood at -$0.16, which was up 5000.0% from -$0.23 recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' EPS (Weighted Average and Diluted) registered a high of $0.38 during Q3 2021, and its lowest value of -$0.7 during Q4 2022.
  • Over the past 5 years, Co-Diagnostics' median EPS (Weighted Average and Diluted) value was -$0.2 (recorded in 2023), while the average stood at -$0.12.
  • Per our database at Business Quant, Co-Diagnostics' EPS (Weighted Average and Diluted) soared by 62000.0% in 2021 and then crashed by 40000.0% in 2023.
  • Co-Diagnostics' EPS (Weighted Average and Diluted) (Quarter) stood at $0.25 in 2021, then tumbled by 377.52% to -$0.7 in 2022, then grew by 28.13% to -$0.5 in 2023, then increased by 27.29% to -$0.36 in 2024, then skyrocketed by 56.0% to -$0.16 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.16 for Q3 2025, versus -$0.23 for Q2 2025 and -$0.24 for Q1 2025.